Search research articles
Contact Us
Filters
Showing results (271-280 of 282) with videos related to
Page
of 29
Sort By:
Journal of Neurosurgery
|
April 1, 2014
Gamma Knife radiosurgery for sellar and parasellar meningiomas: a multicenter study
Jason P Sheehan, Robert M Starke, Hideyuki Kano, et al.
European Urology
|
February 11, 2026
FORMULA-509: A Multicenter Randomized Trial of Postprostatectomy Salvage Radiotherapy and 6 months of a GNRH Agonist with Either Bicalutamide or Abiraterone Acetate plus Prednisone and Apalutamide
Paul L Nguyen, Marisa A Kollmeier, Dana E Rathkopf, et al.
Journal of Neuro-Oncology
|
November 11, 2017
Angiotensin receptor blockade: a novel approach for symptomatic radiation necrosis after stereotactic radiosurgery
Mudit Chowdhary, Derick Okwan-Duodu, Jeffrey M Switchenko, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
November 29, 2016
Patient-reported quality of life after stereotactic body radiation therapy versus moderate hypofractionation for clinically localized prostate cancer
Skyler Bryce Johnson, Pamela R Soulos, Timothy D Shafman, et al.
The Lancet. Oncology
|
April 7, 2020
Pembrolizumab for management of patients with NSCLC and brain metastases: long-term results and biomarker analysis from a non-randomised, open-label, phase 2 trial
Sarah B Goldberg, Kurt A Schalper, Scott N Gettinger, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 17, 2017
Stereotactic radiosurgery of early melanoma brain metastases after initiation of anti-CTLA-4 treatment is associated with improved intracranial control
Yi An, Wen Jiang, Betty Y S Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 24, 2017
Management of Brain Metastases in Tyrosine Kinase Inhibitor-Naïve Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer: A Retrospective Multi-Institutional Analysis
William J Magnuson, Nataniel H Lester-Coll, Abraham J Wu, et al.
Neuro-Oncology
|
November 13, 2018
Estimating survival for renal cell carcinoma patients with brain metastases: an update of the Renal Graded Prognostic Assessment tool
Paul W Sperduto, Brian J Deegan, Jing Li, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 7, 2018
Effect of Targeted Therapies on Prognostic Factors, Patterns of Care, and Survival in Patients With Renal Cell Carcinoma and Brain Metastases
Paul W Sperduto, Brian J Deegan, Jing Li, et al.
Clinical and Translational Radiation Oncology
|
July 26, 2019
Estimating survival in patients with gastrointestinal cancers and brain metastases: An update of the graded prognostic assessment for gastrointestinal cancers (GI-GPA)
Paul W Sperduto, Penny Fang, Jing Li, et al.
Page
of 29
Search research articles
Search
Showing results (271-280 of 282) with videos related to
Sort By:
Page
of 29
Journal of Neurosurgery
|
April 1, 2014
Gamma Knife radiosurgery for sellar and parasellar meningiomas: a multicenter study
Jason P Sheehan, Robert M Starke, Hideyuki Kano, et al.
European Urology
|
February 11, 2026
FORMULA-509: A Multicenter Randomized Trial of Postprostatectomy Salvage Radiotherapy and 6 months of a GNRH Agonist with Either Bicalutamide or Abiraterone Acetate plus Prednisone and Apalutamide
Paul L Nguyen, Marisa A Kollmeier, Dana E Rathkopf, et al.
Journal of Neuro-Oncology
|
November 11, 2017
Angiotensin receptor blockade: a novel approach for symptomatic radiation necrosis after stereotactic radiosurgery
Mudit Chowdhary, Derick Okwan-Duodu, Jeffrey M Switchenko, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
November 29, 2016
Patient-reported quality of life after stereotactic body radiation therapy versus moderate hypofractionation for clinically localized prostate cancer
Skyler Bryce Johnson, Pamela R Soulos, Timothy D Shafman, et al.
The Lancet. Oncology
|
April 7, 2020
Pembrolizumab for management of patients with NSCLC and brain metastases: long-term results and biomarker analysis from a non-randomised, open-label, phase 2 trial
Sarah B Goldberg, Kurt A Schalper, Scott N Gettinger, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 17, 2017
Stereotactic radiosurgery of early melanoma brain metastases after initiation of anti-CTLA-4 treatment is associated with improved intracranial control
Yi An, Wen Jiang, Betty Y S Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 24, 2017
Management of Brain Metastases in Tyrosine Kinase Inhibitor-Naïve Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer: A Retrospective Multi-Institutional Analysis
William J Magnuson, Nataniel H Lester-Coll, Abraham J Wu, et al.
Neuro-Oncology
|
November 13, 2018
Estimating survival for renal cell carcinoma patients with brain metastases: an update of the Renal Graded Prognostic Assessment tool
Paul W Sperduto, Brian J Deegan, Jing Li, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 7, 2018
Effect of Targeted Therapies on Prognostic Factors, Patterns of Care, and Survival in Patients With Renal Cell Carcinoma and Brain Metastases
Paul W Sperduto, Brian J Deegan, Jing Li, et al.
Clinical and Translational Radiation Oncology
|
July 26, 2019
Estimating survival in patients with gastrointestinal cancers and brain metastases: An update of the graded prognostic assessment for gastrointestinal cancers (GI-GPA)
Paul W Sperduto, Penny Fang, Jing Li, et al.
Page
of 29